2022年12月最新中科院JCR期刊分区表数据（升级版）已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Drug Design Development and Therapy DRUG DES DEV THER LetPub评分 6.6
53人评分
我要评分
声誉 7.2 影响力 5.4 速度 9.5 | |||||||||||||||||||||||||
| 期刊ISSN | 1177-8881 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||
| 2021-2022最新影响因子 （数据来源于搜索引擎） | 注册或登录后，查看影响因子和历年趋势图 | |||||||||||||||||||||||||
| 2021-2022自引率 | 2.00%注册或登录后，查看自引率趋势图 | |||||||||||||||||||||||||
| h-index | 48 | |||||||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||||||
| 期刊简介 | Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications. The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas. Specific topics covered by the journal include: Drug target identification and validation Phenotypic screening and target deconvolution Biochemical analyses of drug targets and their pathways New methods or relevant applications in molecular/drug design and computer-aided drug discovery* Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes) Structural or molecular biological studies elucidating molecular recognition processes Fragment-based drug discovery Pharmaceutical/red biotechnology Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products** Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing) Preclinical development studies Translational animal models Mechanisms of action and signalling pathways Toxicology Gene therapy, cell therapy and immunotherapy Personalized medicine and pharmacogenomics Clinical drug evaluation Patient safety and sustained use of medicines. | |||||||||||||||||||||||||
| 期刊官方网站 | https://www.dovepress.com/drug-design-development-and-therapy-journal | |||||||||||||||||||||||||
| 期刊投稿网址 | https://www.dovepress.com/submit_step_1.php | |||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ USD2310; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：drug design、drug safety、drug development、pharmaecuticals 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardBlind peer review | |||||||||||||||||||||||||
| 通讯方式 | PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752 | |||||||||||||||||||||||||
| 出版商 | Dove Medical Press Ltd. | |||||||||||||||||||||||||
| 涉及的研究方向 | CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY | |||||||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||||||
| 出版年份 | 2007 | |||||||||||||||||||||||||
| 年文章数 | 377注册或登录后，查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 95.22% | |||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 80.37% | |||||||||||||||||||||||||
| WOS期刊SCI分区 （ 2021-2022年最新版） | WOS分区等级：2区
| |||||||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月最新升级版） | 注册或登录后，查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月基础版） |
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月升级版） |
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月旧的升级版） |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1177-8881%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： >12周，或约稿 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
| |
| 注册或登录后，查看自引率趋势图 |
| 注册或登录后，查看中科院SCI期刊分区趋势图 |
| 注册或登录后，查看年文章数趋势图 |
| 中国学者近期发表的论文 | |
| 1. | The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1. Author: Tao H1,2, Tang T1,2, Wang S1,2, Wang Z1,2, Ma Y1,2, Cai T1,2, Cheng X1,2, Qi S1,2, Zhang Y1,2, Qi Z1,2. Journal: Drug Des Devel Ther. 2019 Apr 17;13:1221-1231. doi: 10.2147/DDDT.S201818. eCollection 2019. PubMed DOI |
| 2. | Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer. Author: Li S1, Li X1, Ding J1, Han L1, Guo X1. Journal: Drug Des Devel Ther. 2019 Apr 18;13:1271-1280. doi: 10.2147/DDDT.S195493. eCollection 2019. PubMed DOI |
| 3. | Effects of dezocine for the prevention of postoperative catheter-related bladder discomfort: a prospective randomized trial. Author: Zhang GF1, Guo J2, Qiu LL1, Li SM1, Zheng M2, Xia JY1, Yang JJ1,3. Journal: Drug Des Devel Ther. 2019 Apr 23;13:1281-1288. doi: 10.2147/DDDT.S199897. eCollection 2019. PubMed DOI |
| 4. | Safety and sedative effect of intranasal dexmedetomidine in mandibular third molar surgery: a systematic review and meta-analysis. Author: Liu S1,2, Wang Y1,2, Zhu Y1,2, Yu T3, Zhao H1,2. Journal: Drug Des Devel Ther. 2019 Apr 23;13:1301-1310. doi: 10.2147/DDDT.S194894. eCollection 2019. PubMed DOI |
| 5. | Epigallocatechin-3-gallate enhances the osteoblastogenic differentiation of human adipose-derived stem cells. Author: Zhang J1, Wu K2, Xu T3, Wu J1, Li P1, Wang H4, Wu H1, Wu G5. Journal: Drug Des Devel Ther. 2019 Apr 23;13:1311-1321. doi: 10.2147/DDDT.S192683. eCollection 2019. PubMed DOI |
| 6. | Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers. Author: Cao C1, Wang Q1, Liu Y1. Journal: Drug Des Devel Ther. 2019 Apr 5;13:1087-1098. doi: 10.2147/DDDT.S198003. eCollection 2019. PubMed DOI |
| 7. | Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible? Author: Qian YY1, Dai ZJ1, Ruan LY1, Pan YJ1, Jin J1, Shi MT1, Zhu YX1, Wu CM1. Journal: Drug Des Devel Ther. 2019 Apr 10;13:1127-1133. doi: 10.2147/DDDT.S192632. eCollection 2019. PubMed DOI |
| 8. | Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA. Author: Li T1, Lv M1, Chen X1, Yu Y1, Zang G1, Tang Z1. Journal: Drug Des Devel Ther. 2019 Apr 23;13:1289-1300. doi: 10.2147/DDDT.S200610. eCollection 2019. PubMed DOI |
| 9. | Ocular surface squamous neoplasia: angiographic characteristics and response to subconjunctival/perilesional 5-fluorouracil injections. Author: Sun Y1, Hua R1. Journal: Drug Des Devel Ther. 2019 Apr 29;13:1323-1334. doi: 10.2147/DDDT.S191161. eCollection 2019. PubMed DOI |
| 10. | Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway. Author: Liang Y1,2, Feng G1,2, Wu L3, Zhong S1,2, Gao X1,2, Tong Y1,2, Cui W1, Qin Y1, Xu W1, Xiao X1,2, Zhang Z1,2, Huang G1,2, Zhou X1,4. Journal: Drug Des Devel Ther. 2019 Apr 26;13:1335-1345. doi: 10.2147/DDDT.S199182. eCollection 2019. PubMed DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共7条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
